However, Treg-mediated immune suppression, including the transfer of costimulatory molecules, can be impeded by immune checkpoint inhibitors toward CTLA-4 and PD-1/PD-L1, which are used in cancer immunotherapy [73]. Here, CD274 is linked to cancer.